Evidence map›Paper›PMID 28715428›Full record

ArticlePloS one2017

Cip29 is phosphorylated following activation of the DNA damage response in Xenopus egg extracts.

Janet Holden, Elaine M Taylor, Howard D Lindsay

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Janet HoldenLancaster Medical School, Faculty of Health and Medicine, Lancaster University, Lancaster, United Kingdom.
Elaine M TaylorLancaster Medical School, Faculty of Health and Medicine, Lancaster University, Lancaster, United Kingdom.
Howard D LindsayLancaster Medical School, Faculty of Health and Medicine, Lancaster University, Lancaster, United Kingdom.ORCID http://orcid.org/0000-0001-9102-4881
Lancaster University · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acting through a complex signalling network, DNA lesions trigger a range of cellular responses including DNA repair, cell cycle arrest, altered gene expression and cell death, which help to limit the mutagenic effects of such DNA damage. RNA processing factors are increasingly being recognised as important targets of DNA damage signalling, with roles in the regulation of gene expression and also more directly in the promotion of DNA repair. In this study, we have used a Xenopus laevis egg extract system to analyse the DNA damage-dependent phosphorylation of a putative RNA export factor, Cip29. We have found that Cip29 is rapidly phosphorylated in response to DNA double-strand breaks in this experimental system. We show that the DNA damage-inducible modification of Cip29 is dependent on the activity of the key double-strand break response kinase, ATM, and we have identified a conserved serine residue as a damage-dependent phosphorylation site. Finally, we have determined that Cip29 is not required for efficient DNA end-joining in egg extracts. Taken together, these data identify Cip29 as a novel target of the DNA damage response and suggest that the damage-dependent modification of Cip29 may relate to a role in the regulation of gene expression after DNA damage.

Indexed as

DNA RepairAmino Acid SequenceAnimalsAntibodiesAtaxia Telangiectasia Mutated ProteinsCheckpoint Kinase 1DNA-Binding ProteinsDNA Breaks, Double-StrandedMutagenesis, Site-DirectedOvumPhosphorylationPlasmidsRecombinant ProteinsXenopusXenopus ProteinsAntibodiesAtaxia Telangiectasia Mutated ProteinsAtr protein, XenopusCheckpoint Kinase 1DNA-Binding ProteinsRecombinant ProteinsXenopus Proteins

Identifiers

PMID28715428
PMCPMC5513483
OpenAlexW2735227646

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.